Lack G - Search Results

1

Topical steroid withdrawal and atopic dermatitis.

Marshall HF, Leung DYM, Lack G, Sindher S, Ciaccio CE, Chan S, Nadeau KC, Brough HA. Marshall HF, et al. Among authors: lack g. Ann Allergy Asthma Immunol. 2024 Apr;132(4):423-425. doi: 10.1016/j.anai.2023.12.022. Epub 2023 Dec 23. Ann Allergy Asthma Immunol. 2024. PMID: 38142858 Free article. No abstract available.

2

Inhibition of the development of immediate hypersensitivity by staphylococcal enterotoxin B.

Saloga J, Lack G, Bradley K, Renz H, Larsen G, Leung DY, Gelfand EW. Saloga J, et al. Among authors: lack g. Eur J Immunol. 1994 Dec;24(12):3140-7. doi: 10.1002/eji.1830241234. Eur J Immunol. 1994. PMID: 7805743

3

In vivo effects of glucocorticoids on IgE production.

Zieg G, Lack G, Harbeck RJ, Gelfand EW, Leung DY. Zieg G, et al. Among authors: lack g. J Allergy Clin Immunol. 1994 Aug;94(2 Pt 1):222-30. doi: 10.1016/0091-6749(94)90044-2. J Allergy Clin Immunol. 1994. PMID: 8064074

4

Nebulized but not parenteral IFN-gamma decreases IgE production and normalizes airways function in a murine model of allergen sensitization.

Lack G, Renz H, Saloga J, Bradley KL, Loader J, Leung DY, Larsen G, Gelfand EW. Lack G, et al. J Immunol. 1994 Mar 1;152(5):2546-54. J Immunol. 1994. PMID: 8133062

5

Nebulized IFN-gamma inhibits the development of secondary allergic responses in mice.

Lack G, Bradley KL, Hamelmann E, Renz H, Loader J, Leung DY, Larsen G, Gelfand EW. Lack G, et al. J Immunol. 1996 Aug 15;157(4):1432-9. J Immunol. 1996. PMID: 8759723

6

Triggering through CD40 promotes interleukin-4-induced CD23 production and enhanced soluble CD23 release in atopic disease.

Paterson RL, Lack G, Domenico JM, Delespesse G, Leung DY, Finkel TH, Gelfand EW. Paterson RL, et al. Among authors: lack g. Eur J Immunol. 1996 Sep;26(9):1979-84. doi: 10.1002/eji.1830260902. Eur J Immunol. 1996. PMID: 8814234

7

IgE-mediated facilitated antigen presentation underlies higher immune responses in peanut allergy.

Turcanu V, Stephens AC, Chan SM, Rancé F, Lack G. Turcanu V, et al. Among authors: lack g. Allergy. 2010 Oct;65(10):1274-81. doi: 10.1111/j.1398-9995.2010.02367.x. Epub 2010 Apr 7. Allergy. 2010. PMID: 20384616

8

A phase II, randomized, double‑blind, parallel‑group, placebo‑controlled oral food challenge trial of Xolair (omalizumab) in peanut allergy.

Sampson HA, Leung DY, Burks AW, Lack G, Bahna SL, Jones SM, Wong DA. Sampson HA, et al. Among authors: lack g. J Allergy Clin Immunol. 2011 May;127(5):1309-10.e1. doi: 10.1016/j.jaci.2011.01.051. Epub 2011 Mar 11. J Allergy Clin Immunol. 2011. PMID: 21397314 Clinical Trial. No abstract available.

9

Cutaneous lymphocyte antigen and α4β7 T-lymphocyte responses are associated with peanut allergy and tolerance in children.

Chan SM, Turcanu V, Stephens AC, Fox AT, Grieve AP, Lack G. Chan SM, et al. Among authors: lack g. Allergy. 2012 Mar;67(3):336-42. doi: 10.1111/j.1398-9995.2011.02765.x. Allergy. 2012. PMID: 22423373

10

Identifying infants at high risk of peanut allergy: the Learning Early About Peanut Allergy (LEAP) screening study.

Du Toit G, Roberts G, Sayre PH, Plaut M, Bahnson HT, Mitchell H, Radulovic S, Chan S, Fox A, Turcanu V, Lack G; Learning Early About Peanut Allergy (LEAP) Study Team. Du Toit G, et al. Among authors: lack g. J Allergy Clin Immunol. 2013 Jan;131(1):135-43.e1-12. doi: 10.1016/j.jaci.2012.09.015. Epub 2012 Nov 19. J Allergy Clin Immunol. 2013. PMID: 23174658

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

280 results

Search Page

Filters